PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34496965-7 2021 At univariate analysis resistin levels were significantly associated with age, waist circumference, hypertension, tHcy, hsPCR, sVCAM, IL-6, HDL-cholesterol, triglycerides and creatinine levels, but only creatinine, triglycerides, hsCRP, IL-6 and sVCAM were independently associated to resistin levels at stepwise regression analysis. Triglycerides 157-170 resistin Homo sapiens 23-31 34496965-7 2021 At univariate analysis resistin levels were significantly associated with age, waist circumference, hypertension, tHcy, hsPCR, sVCAM, IL-6, HDL-cholesterol, triglycerides and creatinine levels, but only creatinine, triglycerides, hsCRP, IL-6 and sVCAM were independently associated to resistin levels at stepwise regression analysis. Triglycerides 215-228 resistin Homo sapiens 23-31 26089609-11 2015 Plasma resistin levels were well correlated with waist circumference, glucose, triglycerides, waist/hip ratio, systolic and diastolic blood pressure, high density lipoprotein, total cholesterol, serum low density lipoprotein, serum very low density lipoprotein, insulin and insulin resistance. Triglycerides 79-92 resistin Homo sapiens 7-15 30993086-6 2019 Analysis showed that weight, body mass index, triglycerides (TGs), and ET-1 were statistically significant correlated with serum resistin. Triglycerides 46-59 resistin Homo sapiens 129-137 30993086-6 2019 Analysis showed that weight, body mass index, triglycerides (TGs), and ET-1 were statistically significant correlated with serum resistin. Triglycerides 61-64 resistin Homo sapiens 129-137 30925325-5 2019 The present study investigated that resistin could up-regulate the expression of LPL and increase the contents of intracellular triglyceride (TG) and total cholesterol (TC) in RAW264.7 macrophages. Triglycerides 128-140 resistin Homo sapiens 36-44 30925325-5 2019 The present study investigated that resistin could up-regulate the expression of LPL and increase the contents of intracellular triglyceride (TG) and total cholesterol (TC) in RAW264.7 macrophages. Triglycerides 142-144 resistin Homo sapiens 36-44 25945322-12 2015 Serum resistin level was correlated with serum triglyceride, total and low density lipoprotein (LDL) cholesterol (p < 0.05) in GDM patients. Triglycerides 47-59 resistin Homo sapiens 6-14 23734806-3 2013 RESULTS: Adiponectin and resistin concentrations were significantly inversely correlated with BMI standard deviation score, homeostatic model assessment insulin resistance, waist circumference, triglyceride levels and diastolic and systolic blood pressure, and were directly correlated with high-density lipoprotein cholesterol. Triglycerides 194-206 resistin Homo sapiens 25-33 24430788-7 2014 The multivariate models corroborated the positive associations between the resistin level and saturated fat intake(p < 0.001) and serum triglycerides(p=0.004) and the inverse associations between the resistin level and adherence to the Mediterranean diet(p=0.002), total serum cholesterol(p < 0.001) and cholesterol fractions and the waist/height ratio(p=0.02). Triglycerides 139-152 resistin Homo sapiens 75-83 17287419-5 2007 RESULTS: Plasma resistin levels were highly positively correlated with triglycerides, waist circumference, waist/hip ratio, systolic blood pressure, and ApoAI/ApoB ratio, while they were inversely correlated with high density lipoprotein and ApoAI levels. Triglycerides 71-84 resistin Homo sapiens 16-24 22421264-6 2012 Resistin level was not associated with insulin resistance, although it was positively correlated with serum triglycerides (P < .01) and negatively correlated with high-density lipoprotein cholesterol (P < .01). Triglycerides 108-121 resistin Homo sapiens 0-8 21410061-4 2010 METHODOLOGY: Serum resistin was measured by ELISA and correlated to viral aetiology, age, gender, BMI, HOMA-IR, liver steatosis, hepatitis staging and grading, blood glucose, triglycerides and cholesterol in 43 patients with chronic hepatitis C, in 16 with chronic hepatitis B and in 29 healthy controls. Triglycerides 175-188 resistin Homo sapiens 19-27 18081734-7 2008 RESULTS: Serum resistin was higher in subjects with either obesity (P = 0.041), low HDL (P = 0.004), high triglycerides (TG) (P = 0.019), hypertension (HT) (P = 0.001) or atherosclerosis (P = 0.012). Triglycerides 106-119 resistin Homo sapiens 15-23 18081734-7 2008 RESULTS: Serum resistin was higher in subjects with either obesity (P = 0.041), low HDL (P = 0.004), high triglycerides (TG) (P = 0.019), hypertension (HT) (P = 0.001) or atherosclerosis (P = 0.012). Triglycerides 121-123 resistin Homo sapiens 15-23 21447495-6 2011 In group 2, serum resistin was positively correlated with serum troponin I and triglycerides (r=0.59, p<0.05, and r=0.47, p<0.05, respectively), but was negatively correlated with high density lipoprotein cholesterol (r=-0.46, p<0.05). Triglycerides 79-92 resistin Homo sapiens 18-26 20694300-9 2010 CONCLUSION: Circulating resistin concentrations are associated with different inflammatory markers, triglycerides, LDL cholesterol and anthropometric variables in morbid obese patients. Triglycerides 100-113 resistin Homo sapiens 24-32 19727657-9 2010 Multiple linear regression analysis with adjustment for age and sex also showed that the plasma resistin level was significantly associated with serum concentrations of HDL-cholesterol, triacylglycerol and insulin, as well as with BMI. Triglycerides 186-201 resistin Homo sapiens 96-104 17889853-0 2007 Resistin induces lipolysis and re-esterification of triacylglycerol stores, and increases cholesteryl ester deposition, in human macrophages. Triglycerides 52-67 resistin Homo sapiens 0-8 17889853-4 2007 Instead, resistin enhanced fractional turnover of the endogenous triacylglycerol pool, increased uptake and decreased oxidation of exogenous fatty acids, and decreased phosphorylation of acetyl CoA carboxylase, all factors increasing the availability of fatty acyl CoA substrate for acyl CoA: cholesterol acyltransferase-1, thereby enhancing macrophage cholesteryl ester deposition. Triglycerides 65-80 resistin Homo sapiens 9-17 17365928-6 2007 Resistin levels were found to positively correlate with TATM and triglycerides in CAPD patients. Triglycerides 65-78 resistin Homo sapiens 0-8 17365928-10 2007 Resistin levels were positively correlated with TATM and triglycerides in CAPD patients. Triglycerides 57-70 resistin Homo sapiens 0-8 15705777-9 2005 Taken together, the data suggest that recombinant hFIZZ3 can influence adipose metabolism by regulating preadipocyte cell number, adipocyte lipid content, and energy expenditure via accelerating the fatty acid/triglyceride futile cycle. Triglycerides 210-222 resistin Homo sapiens 50-56 16586545-10 2006 Conversely, plasma resistin correlated positively with BMI, blood glucose, triglyceride and insulin resistance index (respectively, r=0.40, P<0.05; r=0.52, P<0.05; r=0.46, P<0.01; r=0.27, P<0.05), and negatively correlated with insulin sensitive index (r=-0.32, P<0.05). Triglycerides 75-87 resistin Homo sapiens 19-27 16961271-9 2006 Pearson analysis revealed that resistin protein was correlated with BMI (r = 0.42), fasting insulin concentration (r = 0.38), IRI (r = 0.34), BF % (r = 0.43) and fasting glucose (r = 0.39), but not with blood pressure, CHOL, TG, HDL-C and LDL-C. Triglycerides 225-227 resistin Homo sapiens 31-39 15705777-5 2005 Recombinant hFIZZ3 facilitates preadipocyte proliferation and stimulates adipocyte triglyceride lipolysis, whereas recombinant mResistin inhibits adipocyte differentiation, with no detectable effect on proliferation or lipolysis. Triglycerides 83-95 resistin Homo sapiens 12-18 15705777-7 2005 In mouse adipose explants, hFIZZ3 accelerates simultaneously triglyceride lipolysis and fatty acid reesterification, as assessed by measurement of glycerol and fatty acid release. Triglycerides 61-73 resistin Homo sapiens 27-33